Contact
searchSearch
HMP Global
Videos

Myth Buster: Nail Findings in Alopecia Areata are Clinically Insignificant

Brittany Craiglow, MD
Riya Gandhi, MA
08/06/2026

Nail involvement in alopecia areata may provide valuable clues about disease severity and prognosis. Dr Brittany Craiglow discusses why these clinical findings deserve greater attention.

© 2026 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Dermatology Learning Network or HMP Global, their employees, and affiliates.

Related Content

FDA Alerts
FDA Approves Baricitinib for Adolescents With Severe Alopecia Areata
09/28/2026
Riya Gandhi, MA
FDA has expanded the indication for baricitinib (Olumiant) to include adolescents aged 12 years and older with severe alopecia areata, based on results from the Phase 3 BRAVE-AA-PEDS trial.
FDA has expanded the indication for baricitinib (Olumiant) to include adolescents aged 12 years and older with severe alopecia areata, based on results from the Phase 3 BRAVE-AA-PEDS trial.
FDA has expanded the indication...
09/28/2026
The Dermatologist
Asempa
Videos
Myth Buster: Shared Decision-Making is Easy in Alopecia Areata
08/06/2026
Oyetewa Boluwatito Asempa, MD, FAAD; Riya Gandhi, MA
Shared decision-making in alopecia areata is often more complex than it appears. Dr Oyetewa Asempa discusses aligning treatment goals, managing expectations, and improving patient-clinician communication.
Shared decision-making in alopecia areata is often more complex than it appears. Dr Oyetewa Asempa discusses aligning treatment goals, managing expectations, and improving patient-clinician communication.
Shared decision-making in...
08/06/2026
The Dermatologist
Draelos
Videos
Myth Buster: Hair Regrowth is the Only Outcome That Matters
08/06/2026
Zoe Diana Draelos, MD; Riya Gandhi, MA
Hair regrowth is only one measure of success in alopecia areata. Dr Zoe Draelos highlights patient-centered outcomes, quality of life, emotional well-being, and long-term disease control.
Hair regrowth is only one measure of success in alopecia areata. Dr Zoe Draelos highlights patient-centered outcomes, quality of life, emotional well-being, and long-term disease control.
Hair regrowth is only one...
08/06/2026
The Dermatologist
Draelos
Videos
Myth Buster: Children are More Resilient to Alopecia Areata Than Adults
08/06/2026
Zoe Diana Draelos, MD; Riya Gandhi, MA
Pediatric alopecia areata can have profound emotional and social consequences. Dr Zoe Draelos examines the unique psychological challenges facing children and adolescents with the disease.
Pediatric alopecia areata can have profound emotional and social consequences. Dr Zoe Draelos examines the unique psychological challenges facing children and adolescents with the disease.
Pediatric alopecia areata can...
08/06/2026
The Dermatologist

Popular Articles

Depressed-woman-sitting-on-edge-of-bed
Quiz
Acne and Depressive Symptoms
02/07/2025
In a comparison of the mental health of patients with acne treated with isotretinoin vs oral antibiotics, which treatment group was found to experience more depressive symptoms and psychological distress?
In a comparison of the mental health of patients with acne treated with isotretinoin vs oral antibiotics, which treatment group was found to experience more depressive symptoms and psychological distress?
In a comparison of the mental...
02/07/2025
The Dermatologist
Jeffrey M. Cohen, MD
Conference Coverage
TYK2 as a Therapeutic Target in Psoriasis
08/11/2025
Coleen Stern, MA
Jeffrey M. Cohen, MD, discussed TYK2 inhibitors, a new class of therapy being studied for the treatment of psoriasis.
Jeffrey M. Cohen, MD, discussed TYK2 inhibitors, a new class of therapy being studied for the treatment of psoriasis.
Jeffrey M. Cohen, MD, discussed...
08/11/2025
The Dermatologist
Dr Adam Friedman
Podcasts
The Real Derm: Episode 5, Diving Deep Into the DermPath Pathway: A Candidate's Perspective
07/10/2025
Adam Friedman, MD
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to dermatology residency is bone breaking enough, but what about the next apex, even more specialized training such as a Dermatopathology Fellowship?
Climbing the mountain to get to...
07/10/2025
The Dermatologist
Dr Yosipovitch
Conference Coverage
Chronic Itch in 2026: Targeting Th2, IL-31, BTK, and Beyond
02/21/2026
Riya Gandhi, MA
A clinical update on chronic pruritus management, highlighting dupilumab, lebrikizumab, nemolizumab, JAK inhibitors, remibrutinib (BTK inhibitor), povorcitinib, and opioid receptor modulators.
A clinical update on chronic pruritus management, highlighting dupilumab, lebrikizumab, nemolizumab, JAK inhibitors, remibrutinib (BTK inhibitor), povorcitinib, and opioid receptor modulators.
A clinical update on chronic...
02/21/2026
The Dermatologist
Chief Medical Editor Message
Restrictions on Off-Label Prescribing?
03/09/2026
Steven R. Feldman, MD, PhD
A colleague recently brought to my attention a New England Journal of Medicine article describing a federal effort to stop off-label prescribing. The email subject line read “Using FDA Law to Threaten Medical Practice.”
A colleague recently brought to my attention a New England Journal of Medicine article describing a federal effort to stop off-label prescribing. The email subject line read “Using FDA Law to Threaten Medical Practice.”
A colleague recently brought to...
03/09/2026
The Dermatologist
october 2026

Current Issue

October 2026
Volume 34
Issue 7
Current Issue
Issue Archive

Latest Quizzes

Quiz
Quiz
Neuroimmune Signaling and Tissue Remodeling in Prurigo Nodularis
11/09/2026
Riya Gandhi, MA
Test your understanding of the complex interactions among inflammatory cytokines, sensory neurons, and tissue remodeling in prurigo nodularis.
Test your understanding of the complex interactions among inflammatory cytokines, sensory neurons, and tissue remodeling in prurigo nodularis.
Test your understanding of the...
11/09/2026
The Dermatologist
Physician with child
Quiz
Pediatric Patients With Atopic Dermatitis Receiving Dupilumab
11/03/2026
Jessica Garlewicz
What proportion of children aged 6 to 11 years with severe atopic dermatitis receiving dupilumab achieved a height increase of at least 5 percentile points after 4 months of treatment?
What proportion of children aged 6 to 11 years with severe atopic dermatitis receiving dupilumab achieved a height increase of at least 5 percentile points after 4 months of treatment?
What proportion of children aged...
11/03/2026
The Dermatologist
magnifying glass in front of stacks of books
Quiz
Therapeutic Response Heterogeneity and Precision Medicine in Type 2 Inflammation
11/02/2026
Riya Gandhi, MA
Evaluate advanced clinical reasoning in targeted treatment selection, unexpected therapeutic responses, and the challenges of precision medicine in inflammatory dermatology.
Evaluate advanced clinical reasoning in targeted treatment selection, unexpected therapeutic responses, and the challenges of precision medicine in inflammatory dermatology.
Evaluate advanced clinical...
11/02/2026
The Dermatologist
Illustration-depicting-knowledge-or-education
Quiz
Neuroimmune Interactions and Disease Persistence in Type 2 Inflammation
11/02/2026
Riya Gandhi, MA
Challenge your understanding of inflammatory feedback mechanisms, neuronal sensitization, and the complex cellular interactions involved in chronic dermatologic disease.
Challenge your understanding of inflammatory feedback mechanisms, neuronal sensitization, and the complex cellular interactions involved in chronic dermatologic disease.
Challenge your understanding of...
11/02/2026
The Dermatologist
Clock for test
Quiz
Understanding Type 2 Inflammation Across Inflammatory Skin Diseases
11/02/2026
Riya Gandhi, MA
Test your clinical understanding of inflammatory disease classification, overlapping immune pathways, and the evolving role of type 2 inflammation in dermatology.
Test your clinical understanding of inflammatory disease classification, overlapping immune pathways, and the evolving role of type 2 inflammation in dermatology.
Test your clinical understanding...
11/02/2026
The Dermatologist
Book with arrows
Quiz
Advanced Therapeutic Sequencing and Personalized Care in Type 2 Inflammatory Skin Disease
10/25/2026
Riya Gandhi, MA
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Challenge your understanding of treatment sequencing, biologic failure, JAK inhibitor escalation, and future biomarker-driven approaches in inflammatory dermatology.
Challenge your understanding of...
10/25/2026
The Dermatologist
AD
Quiz
Precision Therapeutic Selection Across Type 2 Inflammatory Skin Diseases
10/15/2026
Riya Gandhi, MA
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach to selecting targeted therapies across multiple type 2 inflammatory skin diseases by integrating disease biology, symptom burden, and treatment sequencing.
Evaluate your clinical approach...
10/15/2026
The Dermatologist
HS
Quiz
Quiz: Efficacy Findings for Povorcitinib in the Phase 3 STOP-HS1 and STOP-HS2 Trials
10/01/2026
Jessica Garlewicz
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best describes the week 12 efficacy findings for povorcitinib in the phase 3 STOP-HS1 and STOP-HS2 trials in patients with moderate-to-severe hidradenitis suppurativa?
Which of the following best...
10/01/2026
The Dermatologist
itch
Quiz
Clinical Implications of Type 2 Inflammation in Chronic Spontaneous Urticaria
09/21/2026
Riya Gandhi, MA
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of...
09/21/2026
The Dermatologist
random molecule
Quiz
Understanding Type 2 Inflammatory Mechanisms in Chronic Spontaneous Urticaria
09/14/2026
Riya Gandhi, MA
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of...
09/14/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use